University of Texas at Austin
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Texas at Austin sits in the top decile of US sponsors by registered trial count (#129 of 15,742 sponsors by registered trial count).
University of Texas at Austin: 257 sponsored US clinical trials, 59 recruiting.
University of Texas at Austin sponsors 257 registered US clinical trials on ClinicalTrials.gov, 59 of them currently recruiting, and 160 completed. 13 of these trials are in Phase 3-4 (later-stage) and 22 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Post Traumatic Stress Disorder, with 8 trials.
Top-decile sponsor footprint
University of Texas at Austin ranks in the top decile of sponsors by registered trial count (#129 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
160 of 169 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (94.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
257 total, page 5 of 6
A School-based Gardening Obesity Intervention for Low-income Minority Children
NCT02668744
Mirthful Laughter and Muscle Soreness / Pain
NCT02896075
Rates of Recovery From Strenuous Exercise in Physically Active Older Adults
NCT02899650
Spider Phobia Opposite Action Treatment Study
NCT02905279
Cognitive Enhancement Through Transcranial Laser Therapy
NCT02851173
Telehealth Depression Treatments for Older Adults
NCT02600754
Augmenting Internet-Based Cognitive Behavioral Therapy for Major Depressive Disorder With Low-Level Light Therapy
NCT02898233
Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin
NCT02704039
Wonders & Worries: A Clinical Trial of a Psychosocial Intervention for Children Who Have a Parent With Cancer
NCT02758639
Effects of Low-Level Laser Stimulation With and Without Fear Extinction Training
NCT02926352
Strengthening Hispanic Families Via NIDA
NCT03407742
Hormones and Decision Making
NCT04865562
Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
NCT02372110
Destiffening and Hypotensive Effects of Whole Milk and Full-fat Dairy Products
NCT02397902
Effects of Fast Acting Testosterone Nasal Spray on Anxiety
NCT02361190
Exercise and Virtual Reality Exposure Therapy for Acrophobia
NCT02361203
Augmentation Study of A Computerized Treatment for Social Anxiety Disorder
NCT02372019
Neuropsychological Profiles of Pediatric Obsessive Compulsive Disorder (OCD)
NCT02160431
Effect of Caffeine on Heart Function
NCT02401776
Computer Assisted Cognitive Rehabilitation for Persons With Multiple Sclerosis
NCT03200899
Eating Frequency and Visceral Adipose Tissue, Body Fat, and Obesity Risk in Hispanic College Freshmen
NCT03321305
Integrated PTSD and Smoking Treatment
NCT01988935
Enhancing Panic and Smoking Reduction Treatment With D-Cycloserine
NCT01944423
The Effect of Bikram Yoga on Arterial Stiffness and Endothelial Function in Middle-Aged Adults
NCT02488148
Effects of Fluid Milk in Attenuating Hyperglycemia and Hypertriglyceridemia After Meal
NCT02894112
Can Genetics Predict Treatment Response to a Computerized Self-help Program for Depression?
NCT01818453
Regular Swimming, Vascular Function, and Arthritis
NCT01836380
Role of Flavanols in Exercise and Aging
NCT01557738
Bringing What Works to Youth in Corrections: A Trauma Intervention
NCT01560728
Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
NCT01710202
Enhancing Exposure Therapy for Snake and Spider Phobias
NCT02160470
Enhancing Exposure Therapy for Post-traumatic Stress Disorder
NCT01574118
Study on the Effects of Exogenous Testosterone on Threat Perception and Behavioral Avoidance
NCT01408498
Hypotensive Effects of Conventional Dairy Products: Role of Arterial Stiffness
NCT01577030
Role of Flavanols In Cardiovascular Function in Healthy Aging
NCT01395277
XY-Zone Program Evaluation: A School-Based Dropout Prevention Program for At-Risk Youth
NCT01323231
Physical Fitness, Cardiovascular and Brain Health
NCT01341145
Testing the Effectiveness of a Computer-based Program for Depression
NCT01203683
Sexual Health on Antidepressants Through Physical Exercise
NCT01188720
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
NCT01998100
Mechanisms of Insulin Facilitation of Memory
NCT01145482
Effects of Water-soluble Olive Extract Supplementation
NCT01113827
Multidisciplinary Approach to Reduce Injury and Substance Abuse
NCT01048359
ChoicesPlus: Reducing Alcohol- and Tobacco-Exposed Pregnancy
NCT01032772
Community-Based Diabetes Care for Korean American Immigrants
NCT01264796
Comparison of Asthma Programs for Schools
NCT01625364
Feasibility of Telehealth Problem-Solving Therapy for Depressed Homebound Older Adults
NCT00903019
Efficacy of Exercise for Sexual Side Effects of Antidepressants
NCT01189825
Smoking Cessation and Sexual Health in Men
NCT00833404
Asthma in Central Texas Project
NCT01676896
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 16 |
| Phase 2 | 6 |
| Phase 3 | 5 |
| Phase 4 | 8 |
What is open in the University of Texas at Austin pipeline
59 recruiting of 257 indexed (23% open); 160 completed (62%).
Phase mix: 13 late (III/IV) vs 22 early (I/II) (early-phase heavy).
Top condition: Post Traumatic Stress Disorder (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Texas at Austin: open-pipeline peers nationwide
Peers matched on 257 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
University of Texas at Austin sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 257 trials (± recruiting share)
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
- Abbott Medical Devices · 261 trials · 9% recruiting
- Boston Medical Center · 253 trials · 11% recruiting
- University of South Florida · 252 trials · 17% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Icahn School of Medicine at Mount Sinai · 23% recruiting · 708 trials
- Veterans Medical Research Foundation · 23% recruiting · 35 trials
- Clemson University · 23% recruiting · 13 trials
- Liberating Technologies · 23% recruiting · 13 trials
Related
What to do with this University of Texas at Austin page
257 registered trials is a research-attention snapshot, not an endorsement of University of Texas at Austin or any single study.
- 59 of University of Texas at Austin's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Post Traumatic Stress Disorder is the condition University of Texas at Austin studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Post Traumatic Stress Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Texas at Austin pipeline card: 257 registered trials from official public datasets.Report a data error.